Effects of Online Mindfulness Therapy on Pain and Stress in Adults With Chronic Migraine and Adverse Childhood Experiences
Not yet recruitingNot applicableNCT07033520
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study aims to evaluate the effectiveness of an online Mindfulness-Based Cognitive Therapy (MBCT) program in reducing pain, stress-related symptoms, and improving functionality in adults with chronic migraine and a history of adverse childhood experiences (ACE). Participants will be randomly assigned to either the MBCT intervention group or a control group. The intervention is delivered entirely online over eight weeks. The study hypothesizes that MBCT will result in significant improvements in pain perception and stress-related symptoms compared to the control condition.
Study details
- Official title
- Effects of Online Mindfulness-Based Cognitive Therapy on Pain, Stress-Related Symptoms, and Functionality in Adults With Chronic Migraine and Adverse Childhood Experiences at the International Hospital of Colombia
- Conditions
- Chronic Migraine
- Adverse Childhood Experiences
- Depression
- Anxiety
- Headache Disorders
- Interventions
- Behavioral: Online Mindfulness-Based Cognitive Therapy
- Sponsor
- Fundación Cardiovascular de Colombia
- Collaborators
- Universidad de Santander
- Start date
- 2025-07-01
- Primary completion
- 2025-10-20
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Colombia
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Male and female patients aged 18 years or older with a diagnosis of chronic migraine according to the International Classification of Headache Disorders (ICHD-3), based on diagnostic criteria updated through 2018. * Willingness to participate in online sessions from 6:00 PM to 8:00 PM on the scheduled day of the intervention. * Male and female patients with a score of 4 or higher on the Adverse Childhood Experiences Questionnaire. * Patients who provide informed consent. Exclusion Criteria: * Visual, auditory, cognitive, or functional limitations that prevent understanding of therapeutic activities or the ability to perform home tasks. * Presence of systemic inflammatory disorders, including rheumatic and autoimmune diseases. * Active malignancy. * Pregnancy or breastfeeding at the time of the study. * Pre-existing neurological conditions (e.g., epilepsy, neuromuscular disorders, metabolic diseases, among others). * Central nervous system tumors. * Diagnosis of terminal illnesses that prevent follow-up over time.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07033520